drugset / Trial / NCT04309721
Perampanel in Focal Status Epilepticus
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized controlled trial on focal motor status epilepticus (SE), studying the add-on efficacy of the enteral administration of perampanel (PER) to a conventional intravenous antiepileptic drug.
Timeline
- Start
- 2022-11-02
- Primary completion
- 2022-11-02
- Completion
- 2023-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 12 mg | Oral |